Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

This grant supports analytical and clinical validation of molecular, cellular, and imaging biomarkers and assays for cancer detection, diagnosis, prognosis, monitoring, treatment response prediction, prevention, control, pharmacodynamics, and toxicity. It funds laboratory optimization and clinical validation of assays using human samples that address a clearly defined cancer-related clinical need.